Hikma Pharmaceuticals Share News (HIK)
HIK Share
HIK Share
HIK Share
HIK Share
HIK
HIK Share
HIK Level 2
HIK Live
HIK Broker
HIK Directors
HIK Financial
HIK
HIK Short
HIK
Last checked at -
Hedge fund manager Man Group is comfortably the highest yielding stock among FTSE 100 constituents, but a rebasing - a City euphemism for a cut - of the dividend could be on the way, according to Morgan Stanley. The shares are currently yielding 11.77% based on historical dividend payments and thou
Read moreLondon is now handily higher, with the strength of transport groups and miners cancelling out the subdued performance of ex-dividend stocks such as HSBC, Standard Life and Thomas Cook. The main point of interest is confirmation from bus and rail group Arriva that it has had an unsolicited bid appr
Read moreBroker Panmure Gordon was predicting yesterday that results from Hikma would be ahead of market expectations, so the in-line with consensus performance from the generic drugs producer came as a disappointment. The outlook statement also served to sap market enthusiasm for the stock in early trading
Read moreHikma Pharmaceuticals is weighing on the pharmaceutical sector even after it reported a 33% increase in 2009 operating profit and said it was confident of continuing growth. Broker Panmure Gordon was predicting yesterday that results from Hikma would be ahead of market expectations, so the in-line
Read moreArriva has raced into the lead to lead the FTSE 250 after the rail and bus group said it had received an approach about a possible offer. Shares in the company climbed yesterday amid rumours of a possible 700p-a-share bid from German transport operator Deutsche Bahn. Singaporean firm ComfortDelGr
Read moreHikma Pharmaceuticals reported a 33% increase in 2009 operating profit and said it was confident of continuing growth. The Jordan based drug maker said it expects to increase sales in the "low-teens" in 2010. Operating profit rose 33% for the year ended 31 December 2009 to £107.3m. Revenue for the
Read moreIn the absence of any announcements expected from FTSE 100 companies attention may be focused on economic data on Wednesday. Claimant count unemployment for February is expected to show a small rise, following on from the 23,500 increase in January. Forecasting agency IHS Global Insight is tipping
Read moreHikma Pharmaceuticals has signed an exclusive agreement to market BioCryst's H1N1 treatment peramivir with governments in the Middle East and North Africa (MENA) region. 'This agreement reinforces our position as the partner of choice in the MENA region,' said chief executive Said Darwazah. 'BioC
Read morePavel Maslovskiy, chief executive of Petropavlovsk, is taking advantage of the near-record gold price to bank some cash with the sale of £24m worth of shares in the Russian gold miner. Companies associated with Dr Maslovskiy sold 2m shares at £11.93 per share. The off-market sale was to a non-relat
Read moreAlcoholic drinks group Diageo's trading update is expected to report an improvement in full-year pre-tax profits on Thursday, with the market consensus hovering around £2.bn, compared to £2.09bn last year. This is despite an anticipated decline in revenue to around £9.25bn from £10.64bn in the year
Read moreFootsie rounded off its best week since March with more gains. Miners were prominent among the risers. Eurasian Natural Resources, Xstrata, Vedanta Resources and Rio Tinto are doing well. British Airways climbed after saying it is raising £600m, including a £300m convertible issue and another £30
Read moreLondon is heading for its best week in three months as miners climb, while British Airways is flying high despite a £100m first quarter loss. The FTSE 100 got off to a decent start following a late rally on Wall Street last night and better than expected numbers from IBM and Google and has carried
Read moreLondon's blue chips have opened brightly after the late rally on Wall St and better than expected numbers from IBM and Google. British Airways is an early riser despite a £300m convertible issue, shuffling of its pension guarantees to free up another £300m and a first quarter loss of £100m. That lo
Read moreLondon's blue chips are expected to gain in early dealings on Friday with sentiment likely to get a boost from better than expected numbers from IBM and internet giant Google in the US overnight. Traders expect Footsie to open 30 points higher. British Airways has launched a £300m convertible debt
Read moreHikma Pharmaceuticals has signed a licensing agreement for the anti-histamine Bilastine with Spain's Faes Farma for the Middle East & North Africa (MENA) region. Through this agreement Faes Farma grants exclusive rights for the manufacture and distribution of Bilastine to Hikma for 17 MENA countri
Read more
Last checked at